The historic rise of Viagra has consistently remained a benchmark of pharmaceutical success, however its legacy within the broader sector now presents questions about potential gains. Generic versions are diminishing exclusivity , causing worries that betting on companies closely tied to Viagra's previous influence could be a speculative strateg… Read More